Dalton Smart
Vorstandsvorsitzender bei HARPOON THERAPEUTICS, INC.
Vermögen: 578 828 $ am 30.04.2024
Profil
Dalton E.
Smart has held the following positions in his career: Chief Executive Officer at Harpoon Therapeutics, Inc., Senior Vice President-Finance & Global Controller at Merck & Co., Inc., and Central Board Member at Junior Achievement of New Jersey, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MERCK & CO., INC.
0,00% | 04.05.2024 | 4 428 ( 0,00% ) | 578 828 $ | 30.04.2024 |
Aktive Positionen von Dalton Smart
| Unternehmen | Position | Beginn |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 04.12.2023 |
| HARPOON THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
| Junior Achievement of New Jersey, Inc. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Junior Achievement of New Jersey, Inc. | |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
